HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost.
The development of a preventive vaccine against human immunodeficiency virus (HIV-1) infection is the most efficient method to control the epidemic. The ultimate goal is to develop a vaccine able to induce specific neutralizing, non-neutralizing antibodies and cellular mediated immunity (CMI). Humor...
Main Authors: | Juliana de Souza Apostólico, Silvia Beatriz Boscardin, Márcio Massao Yamamoto, Jethe Nunes de Oliveira-Filho, Jorge Kalil, Edecio Cunha-Neto, Daniela Santoro Rosa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4699765?pdf=render |
Similar Items
-
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
by: Annalisa Ciabattini, et al.
Published: (2018-03-01) -
Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers
by: Kwinten Sliepen, et al.
Published: (2021-08-01) -
Heterologous prime-boost vaccine regimens against Chlamydia trachomatis
by: Badamchi-Zadeh, Alexander
Published: (2014) -
Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base
by: Angela R. Corrigan, et al.
Published: (2021-04-01) -
Priming with DNA encoding functional trimers and boosting with soluble trimeric protein elicited tier 2 neutralizing antibodies in non-human primates
by: Chakrabarti BK, et al.
Published: (2012-09-01)